Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 7, 2014AIDS

Is it safe to drop CD4+ monitoring among virologically suppressed patients

View Full Paper
Ask AI
Bookmark
Share

Authors

NFNathan FordWorld Health Organization - PakistanKSKathryn StinsonStellenbosch UniversityMDMary‐Ann DaviesNational Health Laboratory Service

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ford et al. (2014) studied this question.

synapsesocial.com/papers/6ab5caa2f05009e2a0fb7c96https://doi.org/10.1097/qad.0000000000000406
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Can we stop CD4+ testing in patients with HIV-1 RNA suppression on antiretroviral treatment?2013 · 35 citations
  2. 2Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa2010 · 269 citations
  3. 3Is Frequent CD4 + T-Lymphocyte Count Monitoring Necessary for Persons With Counts ≥300 Cells/µL and HIV-1 Suppression?: Figure 1.2013 · 84 citations
  4. 4Executive Summary: Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America2013 · 267 citations
  5. 5Scaling up antiretroviral therapy in resource-limited settings2012 · 85 citations